nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—Lacosamide—Bortezomib—hematologic cancer	0.218	0.492	CrCrCtD
Felbamate—Phenacemide—Vorinostat—hematologic cancer	0.174	0.392	CrCrCtD
Felbamate—L-Phenylalanine—Melphalan—hematologic cancer	0.051	0.115	CrCrCtD
Felbamate—CYP2E1—Thalidomide—hematologic cancer	0.0223	0.0729	CbGbCtD
Felbamate—CYP2E1—Dacarbazine—hematologic cancer	0.0192	0.0626	CbGbCtD
Felbamate—CYP2C19—Bortezomib—hematologic cancer	0.0161	0.0524	CbGbCtD
Felbamate—CYP2E1—Mitoxantrone—hematologic cancer	0.0149	0.0486	CbGbCtD
Felbamate—CYP2C19—Thalidomide—hematologic cancer	0.014	0.0457	CbGbCtD
Felbamate—CYP2C19—Teniposide—hematologic cancer	0.0134	0.0436	CbGbCtD
Felbamate—CYP3A4—Bexarotene—hematologic cancer	0.0127	0.0413	CbGbCtD
Felbamate—CYP2C19—Ifosfamide—hematologic cancer	0.0123	0.0402	CbGbCtD
Felbamate—CYP3A4—Lomustine—hematologic cancer	0.0118	0.0384	CbGbCtD
Felbamate—CYP3A4—Busulfan—hematologic cancer	0.0118	0.0384	CbGbCtD
Felbamate—CYP2C19—Imatinib—hematologic cancer	0.0118	0.0384	CbGbCtD
Felbamate—CYP3A4—Thiotepa—hematologic cancer	0.0105	0.0343	CbGbCtD
Felbamate—CYP2E1—Etoposide—hematologic cancer	0.0094	0.0307	CbGbCtD
Felbamate—CYP3A4—Methoxsalen—hematologic cancer	0.00817	0.0266	CbGbCtD
Felbamate—CYP3A4—Bortezomib—hematologic cancer	0.00777	0.0253	CbGbCtD
Felbamate—CYP2C19—Prednisone—hematologic cancer	0.00776	0.0253	CbGbCtD
Felbamate—CYP2E1—Dexamethasone—hematologic cancer	0.00772	0.0252	CbGbCtD
Felbamate—CYP3A4—Daunorubicin—hematologic cancer	0.00743	0.0242	CbGbCtD
Felbamate—CYP3A4—Cytarabine—hematologic cancer	0.00655	0.0214	CbGbCtD
Felbamate—CYP3A4—Teniposide—hematologic cancer	0.00645	0.0211	CbGbCtD
Felbamate—CYP3A4—Ifosfamide—hematologic cancer	0.00596	0.0194	CbGbCtD
Felbamate—CYP3A4—Imatinib—hematologic cancer	0.00569	0.0186	CbGbCtD
Felbamate—CYP3A4—Ruxolitinib—hematologic cancer	0.00536	0.0175	CbGbCtD
Felbamate—CYP3A4—Nilotinib—hematologic cancer	0.00517	0.0169	CbGbCtD
Felbamate—CYP3A4—Vinorelbine—hematologic cancer	0.00513	0.0167	CbGbCtD
Felbamate—CYP2C19—Dexamethasone—hematologic cancer	0.00484	0.0158	CbGbCtD
Felbamate—CYP3A4—Triamcinolone—hematologic cancer	0.00469	0.0153	CbGbCtD
Felbamate—CYP3A4—Dasatinib—hematologic cancer	0.00457	0.0149	CbGbCtD
Felbamate—CYP3A4—Mitoxantrone—hematologic cancer	0.00451	0.0147	CbGbCtD
Felbamate—CYP3A4—Betamethasone—hematologic cancer	0.00402	0.0131	CbGbCtD
Felbamate—CYP3A4—Prednisolone—hematologic cancer	0.00397	0.013	CbGbCtD
Felbamate—CYP3A4—Prednisone—hematologic cancer	0.00375	0.0122	CbGbCtD
Felbamate—CYP3A4—Irinotecan—hematologic cancer	0.00355	0.0116	CbGbCtD
Felbamate—CYP3A4—Vinblastine—hematologic cancer	0.00316	0.0103	CbGbCtD
Felbamate—CYP3A4—Vincristine—hematologic cancer	0.00311	0.0101	CbGbCtD
Felbamate—CYP3A4—Etoposide—hematologic cancer	0.00285	0.00929	CbGbCtD
Felbamate—CYP3A4—Dexamethasone—hematologic cancer	0.00234	0.00764	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—hematologic cancer	0.00194	0.00633	CbGbCtD
Felbamate—Lacosamide—CA9—hematologic cancer	8.55e-05	1	CrCbGaD
Felbamate—CYP2E1—Biological oxidations—GSTM1—hematologic cancer	2.55e-05	0.000607	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTM1—hematologic cancer	2.52e-05	0.000599	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—hematologic cancer	2.5e-05	0.000593	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—HRAS—hematologic cancer	2.44e-05	0.00058	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	2.4e-05	0.00057	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—JAK2—hematologic cancer	2.38e-05	0.000566	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	2.38e-05	0.000565	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	2.37e-05	0.000562	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK14—hematologic cancer	2.27e-05	0.00054	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	2.26e-05	0.000536	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MET—hematologic cancer	2.24e-05	0.000532	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CDK4—hematologic cancer	2.24e-05	0.000532	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	2.22e-05	0.000529	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HRAS—hematologic cancer	2.21e-05	0.000525	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—hematologic cancer	2.16e-05	0.000512	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NOTCH1—hematologic cancer	2.16e-05	0.000512	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTP1—hematologic cancer	2.14e-05	0.00051	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GMPS—hematologic cancer	2.13e-05	0.000506	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PHYH—hematologic cancer	2.13e-05	0.000506	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FTCD—hematologic cancer	2.13e-05	0.000506	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—hematologic cancer	2.12e-05	0.000503	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PTPN11—hematologic cancer	2.07e-05	0.000492	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CREB1—hematologic cancer	2.01e-05	0.000477	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	1.99e-05	0.000473	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTM1—hematologic cancer	1.97e-05	0.000468	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6R—hematologic cancer	1.96e-05	0.000465	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—MTR—hematologic cancer	1.96e-05	0.000465	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CREBBP—hematologic cancer	1.95e-05	0.000464	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SMPD3—hematologic cancer	1.95e-05	0.000463	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—hematologic cancer	1.94e-05	0.000462	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.94e-05	0.000461	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.88e-05	0.000446	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAP2K1—hematologic cancer	1.87e-05	0.000443	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	1.86e-05	0.000442	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—SRC—hematologic cancer	1.81e-05	0.000431	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—FGF2—hematologic cancer	1.77e-05	0.000422	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—hematologic cancer	1.77e-05	0.00042	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—NRAS—hematologic cancer	1.74e-05	0.000415	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—B3GAT1—hematologic cancer	1.7e-05	0.000405	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ASNS—hematologic cancer	1.7e-05	0.000405	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—DCK—hematologic cancer	1.7e-05	0.000405	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—JAK2—hematologic cancer	1.7e-05	0.000404	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.69e-05	0.000403	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—HRAS—hematologic cancer	1.69e-05	0.000402	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK3—hematologic cancer	1.67e-05	0.000397	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PHYH—hematologic cancer	1.64e-05	0.00039	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GMPS—hematologic cancer	1.64e-05	0.00039	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FTCD—hematologic cancer	1.64e-05	0.00039	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.63e-05	0.000386	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HDC—hematologic cancer	1.61e-05	0.000384	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.55e-05	0.000368	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.53e-05	0.000364	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SMPD3—hematologic cancer	1.5e-05	0.000357	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—KRAS—hematologic cancer	1.5e-05	0.000357	CbGpPWpGaD
Felbamate—Headache—Gemcitabine—hematologic cancer	1.5e-05	7.17e-05	CcSEcCtD
Felbamate—Nausea—Vincristine—hematologic cancer	1.5e-05	7.17e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.5e-05	0.000356	CbGpPWpGaD
Felbamate—Flushing—Epirubicin—hematologic cancer	1.5e-05	7.16e-05	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—hematologic cancer	1.5e-05	7.16e-05	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—hematologic cancer	1.49e-05	7.14e-05	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—hematologic cancer	1.49e-05	7.14e-05	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—hematologic cancer	1.48e-05	7.08e-05	CcSEcCtD
Felbamate—Dyspepsia—Betamethasone—hematologic cancer	1.48e-05	7.08e-05	CcSEcCtD
Felbamate—Dyspepsia—Dexamethasone—hematologic cancer	1.48e-05	7.08e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—CDA—hematologic cancer	1.48e-05	0.000351	CbGpPWpGaD
Felbamate—Urticaria—Triamcinolone—hematologic cancer	1.47e-05	7.04e-05	CcSEcCtD
Felbamate—Dysgeusia—Methotrexate—hematologic cancer	1.47e-05	7.03e-05	CcSEcCtD
Felbamate—Asthenia—Etoposide—hematologic cancer	1.47e-05	7.01e-05	CcSEcCtD
Felbamate—Body temperature increased—Triamcinolone—hematologic cancer	1.47e-05	7.01e-05	CcSEcCtD
Felbamate—Anaphylactic shock—Prednisone—hematologic cancer	1.47e-05	7.01e-05	CcSEcCtD
Felbamate—Oedema—Prednisone—hematologic cancer	1.47e-05	7.01e-05	CcSEcCtD
Felbamate—Decreased appetite—Betamethasone—hematologic cancer	1.46e-05	6.99e-05	CcSEcCtD
Felbamate—Decreased appetite—Dexamethasone—hematologic cancer	1.46e-05	6.99e-05	CcSEcCtD
Felbamate—Nausea—Mitoxantrone—hematologic cancer	1.46e-05	6.98e-05	CcSEcCtD
Felbamate—Nausea—Irinotecan—hematologic cancer	1.46e-05	6.98e-05	CcSEcCtD
Felbamate—Infection—Prednisone—hematologic cancer	1.46e-05	6.96e-05	CcSEcCtD
Felbamate—Fatigue—Dexamethasone—hematologic cancer	1.45e-05	6.94e-05	CcSEcCtD
Felbamate—Fatigue—Betamethasone—hematologic cancer	1.45e-05	6.94e-05	CcSEcCtD
Felbamate—Chills—Epirubicin—hematologic cancer	1.45e-05	6.92e-05	CcSEcCtD
Felbamate—Pruritus—Etoposide—hematologic cancer	1.45e-05	6.92e-05	CcSEcCtD
Felbamate—Pain—Dexamethasone—hematologic cancer	1.44e-05	6.88e-05	CcSEcCtD
Felbamate—Pain—Betamethasone—hematologic cancer	1.44e-05	6.88e-05	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—hematologic cancer	1.44e-05	6.88e-05	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—HRAS—hematologic cancer	1.44e-05	0.000342	CbGpPWpGaD
Felbamate—Tachycardia—Prednisone—hematologic cancer	1.43e-05	6.84e-05	CcSEcCtD
Felbamate—Alopecia—Epirubicin—hematologic cancer	1.43e-05	6.82e-05	CcSEcCtD
Felbamate—Nausea—Gemcitabine—hematologic cancer	1.42e-05	6.8e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—PC—hematologic cancer	1.42e-05	0.000338	CbGpPWpGaD
Felbamate—Vomiting—Cisplatin—hematologic cancer	1.42e-05	6.79e-05	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisone—hematologic cancer	1.42e-05	6.77e-05	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—hematologic cancer	1.41e-05	6.75e-05	CcSEcCtD
Felbamate—Rash—Cisplatin—hematologic cancer	1.41e-05	6.73e-05	CcSEcCtD
Felbamate—Dermatitis—Cisplatin—hematologic cancer	1.41e-05	6.72e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.4e-05	0.000333	CbGpPWpGaD
Felbamate—Diarrhoea—Etoposide—hematologic cancer	1.4e-05	6.69e-05	CcSEcCtD
Felbamate—Anorexia—Prednisone—hematologic cancer	1.4e-05	6.68e-05	CcSEcCtD
Felbamate—Ill-defined disorder—Methotrexate—hematologic cancer	1.39e-05	6.66e-05	CcSEcCtD
Felbamate—Anaemia—Methotrexate—hematologic cancer	1.39e-05	6.63e-05	CcSEcCtD
Felbamate—Feeling abnormal—Betamethasone—hematologic cancer	1.39e-05	6.63e-05	CcSEcCtD
Felbamate—Feeling abnormal—Dexamethasone—hematologic cancer	1.39e-05	6.63e-05	CcSEcCtD
Felbamate—Flushing—Doxorubicin—hematologic cancer	1.39e-05	6.62e-05	CcSEcCtD
Felbamate—Flatulence—Epirubicin—hematologic cancer	1.38e-05	6.62e-05	CcSEcCtD
Felbamate—Tension—Epirubicin—hematologic cancer	1.38e-05	6.59e-05	CcSEcCtD
Felbamate—Gastrointestinal pain—Betamethasone—hematologic cancer	1.38e-05	6.58e-05	CcSEcCtD
Felbamate—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.38e-05	6.58e-05	CcSEcCtD
Felbamate—Dysgeusia—Epirubicin—hematologic cancer	1.38e-05	6.58e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—GBA—hematologic cancer	1.37e-05	0.000326	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC35B2—hematologic cancer	1.37e-05	0.000326	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.37e-05	0.000324	CbGpPWpGaD
Felbamate—Nervousness—Epirubicin—hematologic cancer	1.36e-05	6.52e-05	CcSEcCtD
Felbamate—Malaise—Methotrexate—hematologic cancer	1.35e-05	6.47e-05	CcSEcCtD
Felbamate—Dizziness—Etoposide—hematologic cancer	1.35e-05	6.46e-05	CcSEcCtD
Felbamate—Leukopenia—Methotrexate—hematologic cancer	1.34e-05	6.42e-05	CcSEcCtD
Felbamate—Chills—Doxorubicin—hematologic cancer	1.34e-05	6.4e-05	CcSEcCtD
Felbamate—Urticaria—Betamethasone—hematologic cancer	1.34e-05	6.39e-05	CcSEcCtD
Felbamate—Urticaria—Dexamethasone—hematologic cancer	1.34e-05	6.39e-05	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.34e-05	6.38e-05	CcSEcCtD
Felbamate—Dizziness—Prednisolone—hematologic cancer	1.33e-05	6.38e-05	CcSEcCtD
Felbamate—Asthenia—Triamcinolone—hematologic cancer	1.33e-05	6.36e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—EP300—hematologic cancer	1.33e-05	0.000316	CbGpPWpGaD
Felbamate—Abdominal pain—Betamethasone—hematologic cancer	1.33e-05	6.36e-05	CcSEcCtD
Felbamate—Body temperature increased—Betamethasone—hematologic cancer	1.33e-05	6.36e-05	CcSEcCtD
Felbamate—Abdominal pain—Dexamethasone—hematologic cancer	1.33e-05	6.36e-05	CcSEcCtD
Felbamate—Body temperature increased—Dexamethasone—hematologic cancer	1.33e-05	6.36e-05	CcSEcCtD
Felbamate—Nausea—Cisplatin—hematologic cancer	1.33e-05	6.34e-05	CcSEcCtD
Felbamate—Insomnia—Prednisone—hematologic cancer	1.33e-05	6.34e-05	CcSEcCtD
Felbamate—Alopecia—Doxorubicin—hematologic cancer	1.32e-05	6.31e-05	CcSEcCtD
Felbamate—Paraesthesia—Prednisone—hematologic cancer	1.32e-05	6.29e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—B3GAT1—hematologic cancer	1.31e-05	0.000312	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—DCK—hematologic cancer	1.31e-05	0.000312	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ASNS—hematologic cancer	1.31e-05	0.000312	CbGpPWpGaD
Felbamate—Pruritus—Triamcinolone—hematologic cancer	1.31e-05	6.27e-05	CcSEcCtD
Felbamate—Cough—Methotrexate—hematologic cancer	1.31e-05	6.26e-05	CcSEcCtD
Felbamate—Ill-defined disorder—Epirubicin—hematologic cancer	1.3e-05	6.23e-05	CcSEcCtD
Felbamate—Vomiting—Etoposide—hematologic cancer	1.3e-05	6.22e-05	CcSEcCtD
Felbamate—Anaemia—Epirubicin—hematologic cancer	1.3e-05	6.21e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—SRC—hematologic cancer	1.29e-05	0.000308	CbGpPWpGaD
Felbamate—Agitation—Epirubicin—hematologic cancer	1.29e-05	6.17e-05	CcSEcCtD
Felbamate—Dyspepsia—Prednisone—hematologic cancer	1.29e-05	6.17e-05	CcSEcCtD
Felbamate—Rash—Etoposide—hematologic cancer	1.29e-05	6.16e-05	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	1.29e-05	0.000306	CbGpPWpGaD
Felbamate—Dermatitis—Etoposide—hematologic cancer	1.29e-05	6.16e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.28e-05	0.000305	CbGpPWpGaD
Felbamate—Headache—Etoposide—hematologic cancer	1.28e-05	6.12e-05	CcSEcCtD
Felbamate—Flatulence—Doxorubicin—hematologic cancer	1.28e-05	6.12e-05	CcSEcCtD
Felbamate—Arthralgia—Methotrexate—hematologic cancer	1.28e-05	6.11e-05	CcSEcCtD
Felbamate—Chest pain—Methotrexate—hematologic cancer	1.28e-05	6.11e-05	CcSEcCtD
Felbamate—Myalgia—Methotrexate—hematologic cancer	1.28e-05	6.11e-05	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—HRAS—hematologic cancer	1.28e-05	0.000303	CbGpPWpGaD
Felbamate—Tension—Doxorubicin—hematologic cancer	1.28e-05	6.1e-05	CcSEcCtD
Felbamate—Decreased appetite—Prednisone—hematologic cancer	1.27e-05	6.09e-05	CcSEcCtD
Felbamate—Dysgeusia—Doxorubicin—hematologic cancer	1.27e-05	6.08e-05	CcSEcCtD
Felbamate—Rash—Prednisolone—hematologic cancer	1.27e-05	6.08e-05	CcSEcCtD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	1.27e-05	0.000302	CbGpPWpGaD
Felbamate—Dermatitis—Prednisolone—hematologic cancer	1.27e-05	6.07e-05	CcSEcCtD
Felbamate—Malaise—Epirubicin—hematologic cancer	1.27e-05	6.06e-05	CcSEcCtD
Felbamate—Fatigue—Prednisone—hematologic cancer	1.26e-05	6.04e-05	CcSEcCtD
Felbamate—Headache—Prednisolone—hematologic cancer	1.26e-05	6.04e-05	CcSEcCtD
Felbamate—Discomfort—Methotrexate—hematologic cancer	1.26e-05	6.04e-05	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—hematologic cancer	1.26e-05	6.03e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—VEGFA—hematologic cancer	1.26e-05	0.0003	CbGpPWpGaD
Felbamate—Leukopenia—Epirubicin—hematologic cancer	1.26e-05	6.01e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—MTAP—hematologic cancer	1.26e-05	0.000298	CbGpPWpGaD
Felbamate—Constipation—Prednisone—hematologic cancer	1.25e-05	5.99e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—STAT3—hematologic cancer	1.25e-05	0.000297	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HDC—hematologic cancer	1.25e-05	0.000296	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NRAS—hematologic cancer	1.25e-05	0.000296	CbGpPWpGaD
Felbamate—Palpitations—Epirubicin—hematologic cancer	1.24e-05	5.93e-05	CcSEcCtD
Felbamate—Confusional state—Methotrexate—hematologic cancer	1.24e-05	5.9e-05	CcSEcCtD
Felbamate—Dizziness—Triamcinolone—hematologic cancer	1.23e-05	5.86e-05	CcSEcCtD
Felbamate—Cough—Epirubicin—hematologic cancer	1.23e-05	5.86e-05	CcSEcCtD
Felbamate—Anaphylactic shock—Methotrexate—hematologic cancer	1.23e-05	5.86e-05	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—IL6—hematologic cancer	1.22e-05	0.00029	CbGpPWpGaD
Felbamate—Infection—Methotrexate—hematologic cancer	1.22e-05	5.82e-05	CcSEcCtD
Felbamate—Nausea—Etoposide—hematologic cancer	1.21e-05	5.81e-05	CcSEcCtD
Felbamate—Hypertension—Epirubicin—hematologic cancer	1.21e-05	5.8e-05	CcSEcCtD
Felbamate—Feeling abnormal—Prednisone—hematologic cancer	1.21e-05	5.77e-05	CcSEcCtD
Felbamate—Asthenia—Dexamethasone—hematologic cancer	1.21e-05	5.77e-05	CcSEcCtD
Felbamate—Asthenia—Betamethasone—hematologic cancer	1.21e-05	5.77e-05	CcSEcCtD
Felbamate—Ill-defined disorder—Doxorubicin—hematologic cancer	1.21e-05	5.76e-05	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—hematologic cancer	1.2e-05	5.74e-05	CcSEcCtD
Felbamate—Thrombocytopenia—Methotrexate—hematologic cancer	1.2e-05	5.73e-05	CcSEcCtD
Felbamate—Gastrointestinal pain—Prednisone—hematologic cancer	1.2e-05	5.73e-05	CcSEcCtD
Felbamate—Nausea—Prednisolone—hematologic cancer	1.2e-05	5.73e-05	CcSEcCtD
Felbamate—Arthralgia—Epirubicin—hematologic cancer	1.2e-05	5.72e-05	CcSEcCtD
Felbamate—Myalgia—Epirubicin—hematologic cancer	1.2e-05	5.72e-05	CcSEcCtD
Felbamate—Chest pain—Epirubicin—hematologic cancer	1.2e-05	5.72e-05	CcSEcCtD
Felbamate—Agitation—Doxorubicin—hematologic cancer	1.19e-05	5.71e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—MAPK3—hematologic cancer	1.19e-05	0.000283	CbGpPWpGaD
Felbamate—Anxiety—Epirubicin—hematologic cancer	1.19e-05	5.7e-05	CcSEcCtD
Felbamate—Pruritus—Dexamethasone—hematologic cancer	1.19e-05	5.69e-05	CcSEcCtD
Felbamate—Pruritus—Betamethasone—hematologic cancer	1.19e-05	5.69e-05	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.19e-05	0.000282	CbGpPWpGaD
Felbamate—Hyperhidrosis—Methotrexate—hematologic cancer	1.18e-05	5.66e-05	CcSEcCtD
Felbamate—Discomfort—Epirubicin—hematologic cancer	1.18e-05	5.65e-05	CcSEcCtD
Felbamate—Vomiting—Triamcinolone—hematologic cancer	1.18e-05	5.64e-05	CcSEcCtD
Felbamate—Malaise—Doxorubicin—hematologic cancer	1.17e-05	5.6e-05	CcSEcCtD
Felbamate—Rash—Triamcinolone—hematologic cancer	1.17e-05	5.59e-05	CcSEcCtD
Felbamate—Dry mouth—Epirubicin—hematologic cancer	1.17e-05	5.59e-05	CcSEcCtD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.17e-05	0.000278	CbGpPWpGaD
Felbamate—Dermatitis—Triamcinolone—hematologic cancer	1.17e-05	5.59e-05	CcSEcCtD
Felbamate—Anorexia—Methotrexate—hematologic cancer	1.17e-05	5.58e-05	CcSEcCtD
Felbamate—Urticaria—Prednisone—hematologic cancer	1.16e-05	5.57e-05	CcSEcCtD
Felbamate—Leukopenia—Doxorubicin—hematologic cancer	1.16e-05	5.56e-05	CcSEcCtD
Felbamate—Headache—Triamcinolone—hematologic cancer	1.16e-05	5.56e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.16e-05	0.000276	CbGpPWpGaD
Felbamate—Body temperature increased—Prednisone—hematologic cancer	1.16e-05	5.54e-05	CcSEcCtD
Felbamate—Abdominal pain—Prednisone—hematologic cancer	1.16e-05	5.54e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—TGFB1—hematologic cancer	1.16e-05	0.000275	CbGpPWpGaD
Felbamate—Confusional state—Epirubicin—hematologic cancer	1.16e-05	5.53e-05	CcSEcCtD
Felbamate—Diarrhoea—Dexamethasone—hematologic cancer	1.15e-05	5.51e-05	CcSEcCtD
Felbamate—Diarrhoea—Betamethasone—hematologic cancer	1.15e-05	5.51e-05	CcSEcCtD
Felbamate—Palpitations—Doxorubicin—hematologic cancer	1.15e-05	5.49e-05	CcSEcCtD
Felbamate—Oedema—Epirubicin—hematologic cancer	1.15e-05	5.48e-05	CcSEcCtD
Felbamate—Anaphylactic shock—Epirubicin—hematologic cancer	1.15e-05	5.48e-05	CcSEcCtD
Felbamate—Hypotension—Methotrexate—hematologic cancer	1.14e-05	5.47e-05	CcSEcCtD
Felbamate—Infection—Epirubicin—hematologic cancer	1.14e-05	5.44e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—CDA—hematologic cancer	1.14e-05	0.000271	CbGpPWpGaD
Felbamate—Cough—Doxorubicin—hematologic cancer	1.13e-05	5.42e-05	CcSEcCtD
Felbamate—Thrombocytopenia—Epirubicin—hematologic cancer	1.12e-05	5.37e-05	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—hematologic cancer	1.12e-05	5.36e-05	CcSEcCtD
Felbamate—Tachycardia—Epirubicin—hematologic cancer	1.12e-05	5.35e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—FHL2—hematologic cancer	1.12e-05	0.000266	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.12e-05	5.34e-05	CcSEcCtD
Felbamate—Dizziness—Dexamethasone—hematologic cancer	1.11e-05	5.32e-05	CcSEcCtD
Felbamate—Dizziness—Betamethasone—hematologic cancer	1.11e-05	5.32e-05	CcSEcCtD
Felbamate—Hyperhidrosis—Epirubicin—hematologic cancer	1.11e-05	5.3e-05	CcSEcCtD
Felbamate—Insomnia—Methotrexate—hematologic cancer	1.11e-05	5.3e-05	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—hematologic cancer	1.11e-05	5.29e-05	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—hematologic cancer	1.11e-05	5.29e-05	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—hematologic cancer	1.11e-05	5.29e-05	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—hematologic cancer	1.1e-05	5.27e-05	CcSEcCtD
Felbamate—Nausea—Triamcinolone—hematologic cancer	1.1e-05	5.27e-05	CcSEcCtD
Felbamate—Paraesthesia—Methotrexate—hematologic cancer	1.1e-05	5.26e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—AGRN—hematologic cancer	1.1e-05	0.000261	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PC—hematologic cancer	1.1e-05	0.000261	CbGpPWpGaD
Felbamate—Discomfort—Doxorubicin—hematologic cancer	1.09e-05	5.23e-05	CcSEcCtD
Felbamate—Anorexia—Epirubicin—hematologic cancer	1.09e-05	5.22e-05	CcSEcCtD
Felbamate—Dyspnoea—Methotrexate—hematologic cancer	1.09e-05	5.22e-05	CcSEcCtD
Felbamate—Somnolence—Methotrexate—hematologic cancer	1.09e-05	5.21e-05	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—hematologic cancer	1.08e-05	5.17e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—TNF—hematologic cancer	1.08e-05	0.000257	CbGpPWpGaD
Felbamate—Dyspepsia—Methotrexate—hematologic cancer	1.08e-05	5.15e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—KRAS—hematologic cancer	1.07e-05	0.000255	CbGpPWpGaD
Felbamate—Hypotension—Epirubicin—hematologic cancer	1.07e-05	5.12e-05	CcSEcCtD
Felbamate—Vomiting—Betamethasone—hematologic cancer	1.07e-05	5.12e-05	CcSEcCtD
Felbamate—Vomiting—Dexamethasone—hematologic cancer	1.07e-05	5.12e-05	CcSEcCtD
Felbamate—Confusional state—Doxorubicin—hematologic cancer	1.07e-05	5.11e-05	CcSEcCtD
Felbamate—Decreased appetite—Methotrexate—hematologic cancer	1.07e-05	5.09e-05	CcSEcCtD
Felbamate—Rash—Dexamethasone—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Felbamate—Rash—Betamethasone—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Felbamate—Oedema—Doxorubicin—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Felbamate—Dermatitis—Dexamethasone—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Felbamate—Dermatitis—Betamethasone—hematologic cancer	1.06e-05	5.07e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—GBA—hematologic cancer	1.06e-05	0.000252	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.06e-05	0.000252	CbGpPWpGaD
Felbamate—Fatigue—Methotrexate—hematologic cancer	1.06e-05	5.05e-05	CcSEcCtD
Felbamate—Headache—Betamethasone—hematologic cancer	1.05e-05	5.04e-05	CcSEcCtD
Felbamate—Headache—Dexamethasone—hematologic cancer	1.05e-05	5.04e-05	CcSEcCtD
Felbamate—Infection—Doxorubicin—hematologic cancer	1.05e-05	5.04e-05	CcSEcCtD
Felbamate—Asthenia—Prednisone—hematologic cancer	1.05e-05	5.03e-05	CcSEcCtD
Felbamate—Pain—Methotrexate—hematologic cancer	1.05e-05	5.01e-05	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.04e-05	4.99e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—HMMR—hematologic cancer	1.04e-05	0.000247	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—IDH2—hematologic cancer	1.04e-05	0.000247	CbGpPWpGaD
Felbamate—Thrombocytopenia—Doxorubicin—hematologic cancer	1.04e-05	4.96e-05	CcSEcCtD
Felbamate—Pruritus—Prednisone—hematologic cancer	1.04e-05	4.96e-05	CcSEcCtD
Felbamate—Insomnia—Epirubicin—hematologic cancer	1.04e-05	4.96e-05	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—hematologic cancer	1.04e-05	4.95e-05	CcSEcCtD
Felbamate—Paraesthesia—Epirubicin—hematologic cancer	1.03e-05	4.92e-05	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—hematologic cancer	1.03e-05	4.9e-05	CcSEcCtD
Felbamate—Dyspnoea—Epirubicin—hematologic cancer	1.02e-05	4.89e-05	CcSEcCtD
Felbamate—Somnolence—Epirubicin—hematologic cancer	1.02e-05	4.87e-05	CcSEcCtD
Felbamate—Anorexia—Doxorubicin—hematologic cancer	1.01e-05	4.83e-05	CcSEcCtD
Felbamate—Feeling abnormal—Methotrexate—hematologic cancer	1.01e-05	4.83e-05	CcSEcCtD
Felbamate—Dyspepsia—Epirubicin—hematologic cancer	1.01e-05	4.82e-05	CcSEcCtD
Felbamate—Diarrhoea—Prednisone—hematologic cancer	1e-05	4.79e-05	CcSEcCtD
Felbamate—Gastrointestinal pain—Methotrexate—hematologic cancer	1e-05	4.79e-05	CcSEcCtD
Felbamate—Nausea—Betamethasone—hematologic cancer	1e-05	4.78e-05	CcSEcCtD
Felbamate—Nausea—Dexamethasone—hematologic cancer	1e-05	4.78e-05	CcSEcCtD
Felbamate—Decreased appetite—Epirubicin—hematologic cancer	9.97e-06	4.76e-05	CcSEcCtD
Felbamate—Hypotension—Doxorubicin—hematologic cancer	9.91e-06	4.74e-05	CcSEcCtD
Felbamate—Fatigue—Epirubicin—hematologic cancer	9.88e-06	4.72e-05	CcSEcCtD
Felbamate—CYP3A4—Metabolism—FTCD—hematologic cancer	9.88e-06	0.000235	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GMPS—hematologic cancer	9.88e-06	0.000235	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PHYH—hematologic cancer	9.88e-06	0.000235	CbGpPWpGaD
Felbamate—Constipation—Epirubicin—hematologic cancer	9.8e-06	4.69e-05	CcSEcCtD
Felbamate—Pain—Epirubicin—hematologic cancer	9.8e-06	4.69e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—ARNTL—hematologic cancer	9.78e-06	0.000232	CbGpPWpGaD
Felbamate—Urticaria—Methotrexate—hematologic cancer	9.73e-06	4.65e-05	CcSEcCtD
Felbamate—Dizziness—Prednisone—hematologic cancer	9.69e-06	4.63e-05	CcSEcCtD
Felbamate—Abdominal pain—Methotrexate—hematologic cancer	9.68e-06	4.63e-05	CcSEcCtD
Felbamate—Body temperature increased—Methotrexate—hematologic cancer	9.68e-06	4.63e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—MTAP—hematologic cancer	9.68e-06	0.00023	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.67e-06	4.62e-05	CcSEcCtD
Felbamate—Insomnia—Doxorubicin—hematologic cancer	9.59e-06	4.59e-05	CcSEcCtD
Felbamate—Paraesthesia—Doxorubicin—hematologic cancer	9.53e-06	4.55e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—CA9—hematologic cancer	9.51e-06	0.000226	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACP5—hematologic cancer	9.51e-06	0.000226	CbGpPWpGaD
Felbamate—Dyspnoea—Doxorubicin—hematologic cancer	9.46e-06	4.52e-05	CcSEcCtD
Felbamate—Feeling abnormal—Epirubicin—hematologic cancer	9.45e-06	4.52e-05	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—hematologic cancer	9.43e-06	4.51e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—NCOR2—hematologic cancer	9.39e-06	0.000223	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Epirubicin—hematologic cancer	9.38e-06	4.48e-05	CcSEcCtD
Felbamate—Dyspepsia—Doxorubicin—hematologic cancer	9.34e-06	4.46e-05	CcSEcCtD
Felbamate—Vomiting—Prednisone—hematologic cancer	9.32e-06	4.46e-05	CcSEcCtD
Felbamate—Rash—Prednisone—hematologic cancer	9.24e-06	4.42e-05	CcSEcCtD
Felbamate—Dermatitis—Prednisone—hematologic cancer	9.23e-06	4.41e-05	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—hematologic cancer	9.22e-06	4.41e-05	CcSEcCtD
Felbamate—Headache—Prednisone—hematologic cancer	9.18e-06	4.39e-05	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—hematologic cancer	9.15e-06	4.37e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—HRAS—hematologic cancer	9.11e-06	0.000216	CbGpPWpGaD
Felbamate—Urticaria—Epirubicin—hematologic cancer	9.11e-06	4.35e-05	CcSEcCtD
Felbamate—Pain—Doxorubicin—hematologic cancer	9.07e-06	4.34e-05	CcSEcCtD
Felbamate—Constipation—Doxorubicin—hematologic cancer	9.07e-06	4.34e-05	CcSEcCtD
Felbamate—Body temperature increased—Epirubicin—hematologic cancer	9.06e-06	4.33e-05	CcSEcCtD
Felbamate—Abdominal pain—Epirubicin—hematologic cancer	9.06e-06	4.33e-05	CcSEcCtD
Felbamate—CYP3A4—Metabolism—SMPD3—hematologic cancer	9.04e-06	0.000215	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—IDH1—hematologic cancer	8.94e-06	0.000213	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTO1—hematologic cancer	8.84e-06	0.00021	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCC3—hematologic cancer	8.84e-06	0.00021	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TXN—hematologic cancer	8.84e-06	0.00021	CbGpPWpGaD
Felbamate—Asthenia—Methotrexate—hematologic cancer	8.79e-06	4.2e-05	CcSEcCtD
Felbamate—Feeling abnormal—Doxorubicin—hematologic cancer	8.74e-06	4.18e-05	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—IL6—hematologic cancer	8.72e-06	0.000207	CbGpPWpGaD
Felbamate—Nausea—Prednisone—hematologic cancer	8.71e-06	4.16e-05	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.67e-06	4.15e-05	CcSEcCtD
Felbamate—Pruritus—Methotrexate—hematologic cancer	8.67e-06	4.14e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—SPHK1—hematologic cancer	8.66e-06	0.000206	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FHL2—hematologic cancer	8.63e-06	0.000205	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AGRN—hematologic cancer	8.47e-06	0.000201	CbGpPWpGaD
Felbamate—Urticaria—Doxorubicin—hematologic cancer	8.43e-06	4.03e-05	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—hematologic cancer	8.39e-06	4.01e-05	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—hematologic cancer	8.39e-06	4.01e-05	CcSEcCtD
Felbamate—Diarrhoea—Methotrexate—hematologic cancer	8.38e-06	4.01e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—UGT1A1—hematologic cancer	8.32e-06	0.000198	CbGpPWpGaD
Felbamate—Asthenia—Epirubicin—hematologic cancer	8.23e-06	3.93e-05	CcSEcCtD
Felbamate—Pruritus—Epirubicin—hematologic cancer	8.11e-06	3.88e-05	CcSEcCtD
Felbamate—Dizziness—Methotrexate—hematologic cancer	8.1e-06	3.87e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—SLC22A1—hematologic cancer	8.09e-06	0.000192	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CRABP1—hematologic cancer	8.09e-06	0.000192	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—hematologic cancer	8.04e-06	0.000191	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—IDH2—hematologic cancer	8.03e-06	0.000191	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HMMR—hematologic cancer	8.03e-06	0.000191	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DCK—hematologic cancer	7.9e-06	0.000188	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ASNS—hematologic cancer	7.9e-06	0.000188	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.9e-06	0.000188	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALOX5—hematologic cancer	7.88e-06	0.000187	CbGpPWpGaD
Felbamate—Diarrhoea—Epirubicin—hematologic cancer	7.84e-06	3.75e-05	CcSEcCtD
Felbamate—Vomiting—Methotrexate—hematologic cancer	7.79e-06	3.72e-05	CcSEcCtD
Felbamate—Rash—Methotrexate—hematologic cancer	7.72e-06	3.69e-05	CcSEcCtD
Felbamate—Dermatitis—Methotrexate—hematologic cancer	7.72e-06	3.69e-05	CcSEcCtD
Felbamate—Headache—Methotrexate—hematologic cancer	7.68e-06	3.67e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—NUP98—hematologic cancer	7.63e-06	0.000181	CbGpPWpGaD
Felbamate—Asthenia—Doxorubicin—hematologic cancer	7.61e-06	3.64e-05	CcSEcCtD
Felbamate—Dizziness—Epirubicin—hematologic cancer	7.58e-06	3.62e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.57e-06	0.00018	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ARNTL—hematologic cancer	7.55e-06	0.000179	CbGpPWpGaD
Felbamate—Pruritus—Doxorubicin—hematologic cancer	7.51e-06	3.59e-05	CcSEcCtD
Felbamate—CYP3A4—Metabolism—HDC—hematologic cancer	7.49e-06	0.000178	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ADCY7—hematologic cancer	7.41e-06	0.000176	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOA3—hematologic cancer	7.41e-06	0.000176	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NUP214—hematologic cancer	7.36e-06	0.000175	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA9—hematologic cancer	7.34e-06	0.000174	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACP5—hematologic cancer	7.34e-06	0.000174	CbGpPWpGaD
Felbamate—Vomiting—Epirubicin—hematologic cancer	7.29e-06	3.48e-05	CcSEcCtD
Felbamate—Nausea—Methotrexate—hematologic cancer	7.28e-06	3.48e-05	CcSEcCtD
Felbamate—Diarrhoea—Doxorubicin—hematologic cancer	7.26e-06	3.47e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—NCOR2—hematologic cancer	7.24e-06	0.000172	CbGpPWpGaD
Felbamate—Rash—Epirubicin—hematologic cancer	7.23e-06	3.46e-05	CcSEcCtD
Felbamate—Dermatitis—Epirubicin—hematologic cancer	7.22e-06	3.45e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—MTR—hematologic cancer	7.21e-06	0.000171	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCG2—hematologic cancer	7.21e-06	0.000171	CbGpPWpGaD
Felbamate—Headache—Epirubicin—hematologic cancer	7.18e-06	3.43e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—ENO2—hematologic cancer	7.07e-06	0.000168	CbGpPWpGaD
Felbamate—Dizziness—Doxorubicin—hematologic cancer	7.02e-06	3.35e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—IDH1—hematologic cancer	6.9e-06	0.000164	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—hematologic cancer	6.86e-06	0.000163	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CDA—hematologic cancer	6.85e-06	0.000163	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTO1—hematologic cancer	6.82e-06	0.000162	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCC3—hematologic cancer	6.82e-06	0.000162	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TXN—hematologic cancer	6.82e-06	0.000162	CbGpPWpGaD
Felbamate—Nausea—Epirubicin—hematologic cancer	6.81e-06	3.26e-05	CcSEcCtD
Felbamate—Vomiting—Doxorubicin—hematologic cancer	6.75e-06	3.22e-05	CcSEcCtD
Felbamate—CYP2E1—Metabolism—SDC1—hematologic cancer	6.7e-06	0.000159	CbGpPWpGaD
Felbamate—Rash—Doxorubicin—hematologic cancer	6.69e-06	3.2e-05	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—hematologic cancer	6.68e-06	3.19e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—SPHK1—hematologic cancer	6.68e-06	0.000159	CbGpPWpGaD
Felbamate—Headache—Doxorubicin—hematologic cancer	6.65e-06	3.18e-05	CcSEcCtD
Felbamate—CYP3A4—Metabolism—PC—hematologic cancer	6.59e-06	0.000157	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UGT1A1—hematologic cancer	6.42e-06	0.000152	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GBA—hematologic cancer	6.37e-06	0.000151	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC35B2—hematologic cancer	6.37e-06	0.000151	CbGpPWpGaD
Felbamate—Nausea—Doxorubicin—hematologic cancer	6.3e-06	3.01e-05	CcSEcCtD
Felbamate—CYP2C19—Metabolism—SLC22A1—hematologic cancer	6.24e-06	0.000148	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CRABP1—hematologic cancer	6.24e-06	0.000148	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALOX5—hematologic cancer	6.08e-06	0.000145	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NUP98—hematologic cancer	5.89e-06	0.00014	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTAP—hematologic cancer	5.82e-06	0.000138	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ADCY7—hematologic cancer	5.72e-06	0.000136	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOA3—hematologic cancer	5.72e-06	0.000136	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NQO1—hematologic cancer	5.7e-06	0.000135	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CD44—hematologic cancer	5.7e-06	0.000135	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NUP214—hematologic cancer	5.68e-06	0.000135	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.62e-06	0.000134	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTR—hematologic cancer	5.56e-06	0.000132	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCG2—hematologic cancer	5.56e-06	0.000132	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ENO2—hematologic cancer	5.46e-06	0.00013	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYCS—hematologic cancer	5.39e-06	0.000128	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	5.36e-06	0.000127	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—hematologic cancer	5.29e-06	0.000126	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.21e-06	0.000124	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FHL2—hematologic cancer	5.19e-06	0.000123	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SDC1—hematologic cancer	5.17e-06	0.000123	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AGRN—hematologic cancer	5.09e-06	0.000121	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.94e-06	0.000117	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.88e-06	0.000116	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—IDH2—hematologic cancer	4.83e-06	0.000115	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HMMR—hematologic cancer	4.83e-06	0.000115	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—hematologic cancer	4.75e-06	0.000113	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.66e-06	0.000111	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.54e-06	0.000108	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—hematologic cancer	4.5e-06	0.000107	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA9—hematologic cancer	4.41e-06	0.000105	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACP5—hematologic cancer	4.41e-06	0.000105	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CD44—hematologic cancer	4.4e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NQO1—hematologic cancer	4.4e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NCOR1—hematologic cancer	4.37e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—hematologic cancer	4.37e-06	0.000104	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.36e-06	0.000104	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.31e-06	0.000102	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYCS—hematologic cancer	4.16e-06	9.89e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—IDH1—hematologic cancer	4.15e-06	9.86e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	4.13e-06	9.82e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTO1—hematologic cancer	4.1e-06	9.75e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TXN—hematologic cancer	4.1e-06	9.75e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCC3—hematologic cancer	4.1e-06	9.75e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SPHK1—hematologic cancer	4.02e-06	9.54e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.86e-06	9.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.86e-06	9.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.75e-06	8.92e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.75e-06	8.92e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.72e-06	8.84e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.67e-06	8.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.66e-06	8.69e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.55e-06	8.43e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NUP98—hematologic cancer	3.54e-06	8.42e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.47e-06	8.25e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.44e-06	8.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.44e-06	8.17e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NUP214—hematologic cancer	3.41e-06	8.11e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.37e-06	8.01e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.37e-06	8.01e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTR—hematologic cancer	3.34e-06	7.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.34e-06	7.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ENO2—hematologic cancer	3.28e-06	7.79e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CG—hematologic cancer	3.24e-06	7.71e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.18e-06	7.56e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SDC1—hematologic cancer	3.11e-06	7.39e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.01e-06	7.15e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.98e-06	7.08e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.85e-06	6.77e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALB—hematologic cancer	2.81e-06	6.69e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.69e-06	6.4e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NQO1—hematologic cancer	2.64e-06	6.28e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CD44—hematologic cancer	2.64e-06	6.28e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.62e-06	6.24e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.5e-06	5.95e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYCS—hematologic cancer	2.5e-06	5.94e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.49e-06	5.91e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.49e-06	5.91e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.32e-06	5.51e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.21e-06	5.24e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.2e-06	5.23e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALB—hematologic cancer	2.17e-06	5.16e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—hematologic cancer	2.15e-06	5.1e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.09e-06	4.96e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.08e-06	4.94e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—EP300—hematologic cancer	2.05e-06	4.87e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.03e-06	4.82e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.03e-06	4.82e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.92e-06	4.56e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.79e-06	4.26e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—hematologic cancer	1.66e-06	3.94e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—EP300—hematologic cancer	1.58e-06	3.75e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.52e-06	3.6e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.5e-06	3.58e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.4e-06	3.32e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.32e-06	3.14e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALB—hematologic cancer	1.31e-06	3.1e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.25e-06	2.97e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—hematologic cancer	1.24e-06	2.94e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.17e-06	2.78e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.15e-06	2.74e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—hematologic cancer	9.96e-07	2.37e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—hematologic cancer	9.55e-07	2.27e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—EP300—hematologic cancer	9.5e-07	2.26e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	7.03e-07	1.67e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—hematologic cancer	5.74e-07	1.36e-05	CbGpPWpGaD
